PAM
TTPH

Princeton Alpha Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Princeton Alpha Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-529
Closed -$45K – 1014
2016
Q2 		$45K Buy
+529
New +$48.5K 0.01% 746

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Princeton Alpha Management's TTPH Position: Q3 2016 in Review

Princeton Alpha Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2016, closing a stake of 529 shares — an estimated $45K sold.

Princeton Alpha Management first reported a position in TTPH in Q2 2016 and held it in 1 quarter. The position peaked at $45K in Q2 2016. 90 funds tracked by Wall St. Rank hold TTPH as of Q3 2016.

  • Princeton Alpha Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 529 Tetraphase Pharmaceuticals, Inc. shares in Q3 2016, an estimated $45K.
  • Princeton Alpha Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2016 and held it in 1 quarter.
  • Princeton Alpha Management's Tetraphase Pharmaceuticals, Inc. position peaked at $45K in Q2 2016.
  • 90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2016.

Based on Princeton Alpha Management's 13F filing for Q3 2016, filed 10 Nov 2016.